GlyTherix Ltd
PrivateLast Round
Series B
Feb 16, 2024
Total Funding Raised
$2.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlyTherix Ltd operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Series A round in July 2023.
GlyTherix Ltd is a biotechnology company that develops a targeted radiotherapy platform designed to treat solid tumors by delivering antibody radiopharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlyTherix Ltd Comparables
Compare GlyTherix Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precirix | 82% | |
| Alpha-9 Oncology | 79% | |
| Radiopharm Theranostics | 77% |
For institutional investors. Book with your work email.
GlyTherix Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 16, 2024 | ||||
| Series A | Jul 22, 2023 | ||||
| Grant | Sep 8, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
| Grant | Mar 3, 2021 | ||||
Grant | Jul 16, 2020 |
For institutional investors. Book with your work email.
GlyTherix Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Queensland | Grant |
| Australian Research Council | Grant |
| Therapeutic Innovation Australia | Grant |
| NSW Government | Grant |
| Australian Federal Government (Cooperative Research Centres Projects grant) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 87% MoM, reaching 2.4K.
- Jan 8, 2026
Monthly visitors increased 118% MoM, reaching 2K.
For institutional investors. Book with your work email.
GlyTherix Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlyTherix Ltd's valuation, stock price, and market status.
Is GlyTherix Ltd a public or private company?
GlyTherix Ltd is a private company.
What is the current stock price of GlyTherix Ltd?
GlyTherix Ltd is a private company, so its shares have no public market price. Caplight tracks GlyTherix Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlyTherix Ltd worth (valuation)?
Valuation information for GlyTherix Ltd is not publicly available.
Can I buy GlyTherix Ltd stock?
GlyTherix Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlyTherix Ltd's last funding round?
GlyTherix Ltd's most recent funding round was Series B on February 16, 2024.
Who are the main investors in GlyTherix Ltd?
Key investors in GlyTherix Ltd include Australian Research Council, Therapeutic Innovation Australia, NSW Government, Australian Federal Government (Cooperative Research Centres Projects grant).
Will GlyTherix Ltd IPO soon?
No public IPO plans have been announced for GlyTherix Ltd.
How can I track GlyTherix Ltd secondary market activity?
Caplight tracks bids, offers, and trades in GlyTherix Ltd's shares on secondary markets.